Home/Filings/4/0001567619-20-004475
4//SEC Filing

Campbell James H 4

Accession 0001567619-20-004475

CIK 0000722723other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 4:54 PM ET

Size

9.7 KB

Accession

0001567619-20-004475

Insider Transaction Report

Form 4
Period: 2020-02-18
Campbell James H
SVP, Chief Clinical Officer
Transactions
  • Award

    Common Stock

    2020-02-18+4,40524,557 total
Holdings
  • Stock Options (right to buy)

    Exercise: $12.77Exp: 2027-05-19Common Stock (27,328 underlying)
    27,328
  • Performance Share Units

    Exp: 2020-05-19Common Stock (10,931 underlying)
    10,931
Footnotes (6)
  • [F1]Represents performance shares being issued to the reporting person based on the achievement of performance targets for the period beginning January 1, 2019 and ending on December 31, 2019. These performance shares vest in equal tranches over a four year period, commencing on the first anniversary of the grant date.
  • [F2]Consists of (i) unvested restricted shares totaling 4,405 shares of stock from an initial grant of 4,405 shares of restricted stock that begins to vest on March 8, 2020; (ii) unvested restricted shares totaling 5,220 shares of stock from an initial grant of 5,220 shares of restricted stock that begins to vest on March 8, 2020; (iii) unvested restricted shares and fully vested shares totaling 6,268 shares of stock from an initial grant of 6,710 shares of restricted stock made on March 9, 2018; (iv) unvested restricted shares and fully vested shares totaling 4,820 shares of stock from an initial grant of 7,029 shares of restricted stock made on March 8, 2017; [continued in next footnote]
  • [F3](v) unvested restricted shares and fully vested shares totaling 1,316 shares of stock from an initial grant of 3,000 shares of restricted stock made on October 11, 2016; and (vi) unvested restricted shares and fully vested shares totaling 2,528 shares of stock from an initial grant of 6,008 shares of restricted stock made on April 29, 2016.
  • [F4]Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant.
  • [F5]Stock options were granted under the Company's Special Equity Plan and vest 1/3 on each of May 19, 2018, 2019 and 2020.
  • [F6]Performance Share Units ("PSUs") were granted under the Company's Special Equity Plan. Each PSU represents a contingent right to receive one share of common stock if predetermined levels of absolute common stock price compounded annual growth rate are achieved over a three-year performance period ending on the third anniversary of the grant date. The number of PSUs shown in the table represents the maximum number that could be earned; the target number is one-half the maximum number.

Documents

1 file

Issuer

HANGER, INC.

CIK 0000722723

Entity typeother

Related Parties

1
  • filerCIK 0001757390

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 4:54 PM ET
Size
9.7 KB